Human Dendritic Cell Differentiation Mix

Dendritic cell differentiation from human monocytes

SPECIFICATIONS

Specifications

Appearance (form)
Lyophilized
Appearance (color)
White
Reconstitution buffer
1% PBS-BSA (not provided)
Working concentration

See Technical Data Sheet (TDS)

Endotoxin

The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue-Lucia™ hTLR2 and HEK‑Blue-Lucia™ mTLR4 cells

Quality control

Each lot is validated for successful polarization of THP1-Dual™ cells by morphological assessment using microscopy and cell surface marker analysis by flow cytometry

Additional information

Each vial of DC Polarization Mix is sufficient for the polarization of 2.5 × 107 cells

CONTENTS

Contents

  • Product: 
    DC Differentiation Mix
  • Cat code: 
    mix-dc
  • Quantity: 
    1 vial
Notes:

Each vial of DC Polarization Mix is sufficient for the polarization of 2.5 × 107 cells

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: -20°C for up to 1 year when lyophilized and up to 6 months after resuspension

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

Monocyte differentiation and polarization

Monocytes are circulating innate immune cells that can differentiate into macrophages or dendritic cells (DCs) in response to environmental signals. Monocytes can differentiate in vitro into M0 macrophages, commonly using M-CSF or GM-CSF, and subsequently acquire different functional states, including M1- and M2-like phenotypes [1,2]. M1 macrophage polarization is promoted by inflammatory signals such as IFN-γ and microbial stimuli such as LPS. M1-like macrophages contribute to antimicrobial and pro-inflammatory responses and produce mediators including TNF-α, IL-1β, IL-6, and IL-12 [1,3]. In contrast, M2 macrophage polarization is promoted by cytokines such as IL-4 and IL-13. M2-like macrophages are associated with immunoregulation, inflammation resolution, and tissue repair and can produce regulatory mediators such as IL-10 and TGF-β [1,3].

DC differentiation in vitro  is commonly induced by GM-CSF and IL-4, while additional stimuli can promote their activation and maturation. TNF-α promotes DC maturation and the expression of co-stimulatory molecules, whereas ionomycin, a calcium ionophore, induces intracellular Ca²⁺ signaling and can promote DC activation and maturation [4,5]. The combination of GM-CSF, IL-4, TNF-α, and ionomycin has also been used to generate mature DC-like cells from THP-1 cells [5]. DCs capture and process antigens, present antigen-derived peptides to T cells, and produce cytokines that shape subsequent immune responses [4,5].

Altered macrophage polarization and DC function have been associated with autoimmune and inflammatory diseases, including rheumatoid arthritis and systemic lupus erythematosus, as well as cancer [1,6,7].

 

Morphological and phenotypic features

Monocyte differentiation and polarization are accompanied by changes in cell morphology and molecular marker expression. M0 macrophages acquire an adherent macrophage-like morphology following differentiation. Further polarization results in distinct morphological and phenotypic features, although these can vary according to the cell source, stimulus, and experimental conditions [2,8,9].

M1-like macrophages can display a spread or spindle-shaped morphology and are commonly associated with markers such as CD80, IDO1, and CXCL10. M2-like macrophages can display elongated or clustered morphologies and are commonly associated with markers CD200R1, CD206, and TGM2 [1–3,8,9]. As macrophage phenotypes are highly plastic, combinations of morphological and molecular markers are generally more informative than individual markers for characterizing polarization states [1,3].

DC differentiation is accompanied by changes in cell adherence and morphology, including the development of cellular projections characteristic of dendritic cells. Their phenotype can be characterized by the expression of DC-associated markers such as CD209 (DC-SIGN), together with changes in other differentiation- and activation-associated markers [4,5].

 

In vitro models for polarization studies

Human peripheral blood CD14+ monocytes provide a physiologically relevant primary model for studying macrophage polarization and DC differentiation. However, their experimental use can be limited by donor-to-donor variability and cell availability [2,4]. In contrast, THP-1 cells provide a renewable and more homogeneous human monocytic cell model, facilitating standardized experiments and reducing some of the biological variability associated with primary cells. THP-1 cells can be differentiated into macrophage-like cells and subsequently polarized toward M1- or M2-like phenotypes, although differentiation and polarization protocols vary between studies [2,3,8,9]. They can also be differentiated toward DC-like phenotypes, providing a reproducible model for studying DC differentiation and activation [5].

Primary CD14+ monocytes and THP-1 cells therefore provide complementary experimental models: primary cells offer greater physiological relevance, whereas THP-1 cells provide a renewable and standardized system suited to reproducible experiments, genetic manipulation, and reporter-based functional studies [2,5,8,9]. InvivoGen has developed M1 and M2 Polarization Mixes and DC Differentiation Mix, with dedicated protocols adapted to each cell model, enabling standardized generation of M1 and M2 macrophages and differentiated DCs (see figure).

 

References:

1. Luo M. et al., 2024. Macrophage polarization: an important role in inflammatory diseases. Front. Immunol. 15:1352946.
2. Mohd Y.Z. et al., 2022. Macrophage polarization in THP-1 cell line and primary monocytes: A systematic review. Differentiation 128:67–82.
3. Orecchioni M. et al., 2019. Macrophage polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS−) vs. alternatively activated macrophages. Front. Immunol. 10:1084.
4. Segura E. et al., 2025. Monocyte-Derived Dendritic Cells: An Updated View on an Old Concept. Immunol. Rev.
5. Hölken J.M., Teusch N., 2023. The Monocytic Cell Line THP-1 as a Validated and Robust Surrogate Model for Human Dendritic Cells. Int. J. Mol. Sci. 24:1452.
6. Yamada S. et al., 2025. Dendritic cell heterogeneity and its role in connective tissue diseases. Inflamm. Regen. 45:24.
7. Moon C. et al., 2025. Dendritic cell maturation in cancer. Nat. Rev. Cancer 25(4):225–248.
8. Forrester M.A. et al., 2018. Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens. Cell Immunol. 332:58–76.
9. Klatt S. et al., 2026. Comparison of THP-1 Subtypes Reveals Differences on Transcriptomic and Protein Expression Level Throughout Their Immunological Differentiation. J. Immunol. Res. 2026:e9427482.
 

DOCUMENTS

Documents

DC Differentiation Mix

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?